Abstract
The goal of this review is to discuss the surgical technique of Targeted Muscle Reinnervation (TMR) in the oncologic population. The technique not only improves myoelectric prosthetic control, but is a method to relieve post-amputation chronic residual and phantom limb pain. TMR is a surgical procedure that effectively amplifies neural control signals on surface musculature. Fortuitously, TMR has also been shown to also reduce chronic residual and phantom limb pain when performed in a delayed or immediate manner. While most data exists in traumatic or orthopedic amputees, TMR is an emerging technique in the oncologic population. Although important for prosthetic control, it is arguably most beneficial for the oncologic population due to the ability to reduce pain without opioids. TMR improves myoelectric prosthesis control and early results demonstrate marked improvement in post-amputation chronic pain and quality of life within the oncologic population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
